期刊文献+

胰岛素泵在溃疡型糖尿病足感染中的应用及评价 被引量:5

The application and the appraisal of the insulin pumps to patients suffering from diabetes complicated diabetic foots
原文传递
导出
摘要 目的 探讨胰岛素泵在溃疡型糖尿病足感染中的应用.方法 选择2009年~2013年溃疡型糖尿病足感染患者30例,根据不同胰岛素给药方法分两组进行胰岛素强化治疗:胰岛素泵持续皮下输注治疗(CSII) 15例;多次皮下注射胰岛素治疗(MSII) 15例.观察患者血糖达标时间、低血糖发生率、平均住院日及溃疡愈合情况.结果 CSII组与MSII组患者比较,其血糖达标时间短、低血糖发生率低、平均住院日少及溃疡愈合好.结论 胰岛素泵治疗是溃疡型糖尿病足感染中控制血糖的最佳方法,其快速降低血糖、减少低血糖发生,缩短住院天数,溃疡愈合快,疗效确切. Objective To explore the application of insulin pumps to patients suffering from dia- betes complicated diabetic loots. Methods Choose 30 perioperative therapeutic cases which were suffer- ing from diabetes complicated diabetic loots from 2009 to 2013 ,and divide to two groups according to the different insulin for the medieine method to carry on the insulin strengthening treatment, 15 eases received eontinne-subentaneous insulin infusion (CSII), 15 eases received mnltisubentaneous znsulin injection (MSII). Compared with each group situation, such as the average recovering time of blood glucose, inci- dence of hypoglycemia, the average days of hospitalization and ulcer healing situation in patients with dia- betic foot ulcer. Results The CSII group compares the MSII group,the therapeutic time was shorter,the incidence of hypoglycemia event was lower, the average days of hospitalization were shorter, ulcer healing situation was better. Conclusion The treatment of insulin pumps is the best method to cure the patients suffering from diabetes complicated diabetic foots. It has significant effects on rapidly reducing the level of blood glucose and the episodes of hypoglycemia, shortening the days of hospitalization and promoting ulcer healing.
出处 《临床内科杂志》 CAS 2013年第12期812-814,共3页 Journal of Clinical Internal Medicine
基金 国家自然科学基金资助项目(81370965) 2012年江苏省卫生厅科技项目(H2012047) 镇江市2012年第5批科技计划项目(SH2012027) 江苏大学临床科技发展基金资助项目(JLY2010112、JLY2010128)
关键词 胰岛素泵 溃疡型 糖尿病足 The insulin pumps Ulcerative type Diabetic foots
  • 相关文献

参考文献10

  • 1Amiri AA,Hashemi-Soteh MB,Haghshenas MR,et al.Haptoglobin polymorphism in individuals with type 2 diabetic microangiopathy.Med Sci,2013,5:562-566. 被引量:1
  • 2焦秀敏,武晋晓,张星光,吕肖锋.早期胰岛素泵强化治疗对初发2型糖尿病患者血胰高血糖素样肽-1的影响[J].临床内科杂志,2012,29(2):110-111. 被引量:6
  • 3谷涌泉,张建,许樟荣主编..糖尿病足病诊疗新进展[M].北京:人民卫生出版社,2006:408.
  • 4Sohn MW,Budiman-Mak E,Stuck RM,et al.Diagnostic accuracy of existing methods for identifying diabetic foot ulcers from inpatient datasets.Foot Ankle Res,2010,3:27. 被引量:1
  • 5Boulton A J,Vileikyte L,Ragnarson-Tennvall G,et al.The global burden of diabetic foot disease.Lancet,2005,366:1719-1724. 被引量:1
  • 6谷涌泉,张建,郭连瑞,汪忠镐,张淑文,齐立行,徐娟,冀冰心,李建新,俞恒锡,李学锋,崔世军,罗涛,武欣,董宗俊.自体骨髓干细胞移植治疗下肢严重缺血:32例报告[J].中国临床康复,2004,8(35):7970-7972. 被引量:69
  • 7Stratton IM,Holman RR,Boulton ALM.Risk factors for neuropathy in the UKPDS.Diabetologia,2004,29:2847-2850. 被引量:1
  • 8王亮,窦京涛,敖国昆,张妍,申晶,吕波,菅小红,常小燕.2型糖尿病合并下肢血管病变血管介入治疗观察[J].山西医科大学学报,2007,38(10):932-934. 被引量:6
  • 9Vii ES,Shelenyi J,Shemeczy ZS,et al.Enhanced tumor necrosis factor specifir and decreased interlenRin-10-Specific immame reponses to LPS during thethird trimester of pregmacy in mice.Endocrind,2001,171:355-361. 被引量:1
  • 10Redmen CW,Sacks GP,Sargentii.Preechampsia anevressive maternal inflamm atary respone to pregamcy.Am J obstet Gymecal,1999,180:499-506. 被引量:1

二级参考文献15

  • 1张国珍.临床抗生素应用情况调查及分析[J].山西医科大学学报,2006,37(7):710-711. 被引量:6
  • 2Rossi MC,Nicolucci A.Liraglutide in type 2 diabetes:from pharmacological development to clinical practice.Acta Biomed,2009,80:93-101. 被引量:1
  • 3Kendall DM,Cuddihy RM,Bergensta RM.Clinical application of incretin-based therapy:therapeutic potential,patient selection and clinical use.Eur Intem Med,2009,20:S329-339. 被引量:1
  • 4Vilsboll T,Brock B,Perrild H,et al.Liraglutide,aonce daily human GLP-1 analogue,improves pancreatic B cell function and arginine stimulated insulin secretion during hyperglycaemia in patients with type 2 diabetes mellitus.DiabetMed,2008,25:152-156. 被引量:1
  • 5Garber A,Henry R,Ratner R,et al.Liraglutide versusglim epiridem on therapy for 2 diabetes (LEAD-3Mono):a randomized,52-week,phase 3,double-blind parallel-treatment trial.Lancet,2009,373:473-481. 被引量:1
  • 6Zinman B,Gerich J,Buse B,et al.Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolinedionedione in patients with type 2diabetes(LEAD-4Met +TZD).Diabetes Care,2009,32:1224-1230. 被引量:1
  • 7DoyleME,Egan JM.Mechanisms of action of glucagon-like peptide 1 in the pancreas.Phamacol Ther,2007,113:546-593. 被引量:1
  • 8Tibaduiza EC,Chen C,Beinbom M.A smallmolecule ligand of the glucagon-like peptide 1 receptor targets its amino-teminal homone binding domain.J Biol Chem,2001,276:37787-37793. 被引量:1
  • 9Tateishi-Yuyama E,Matsubara H,Murohara T,et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells:a pilot study and a randomised controlled trial.Lancet 2002;360(9331):427-35 被引量:1
  • 10Gu YQ Determination of amputation level in ischaemic lower limbs.ANZ J Surg 2004;74(1-2):3l-3 被引量:1

共引文献78

同被引文献26

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部